SCHEMBL2493987

SCHEMBL2493987

Cc1ccnc2nc[nH]c12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 11/20 0.51
ALDH1A1 P00352 1/20 0.46
PDPK1 O15530 2/20 0.41
LRRK2 Q5S007 2/20 0.41
HSD17B10 Q99714 2/20 0.41
CHEK1 O14757 1/20 0.41
AURKA O14965 1/20 0.41
CHEK2 O96017 1/20 0.41
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
PRKACA P17612 1/20 0.41
CCNE1 P24864 1/20 0.41
CDK2 P24941 1/20 0.41
MARK3 P27448 1/20 0.41
RPS6KA3 P51812 1/20 0.41
PRKCD Q05655 1/20 0.41
MARK2 Q7KZI7 1/20 0.41
TP53 P04637 1/20 0.41
PI4KA P42356 2/20 0.41
PI4K2B Q8TCG2 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30788403 0.74 ALDH1A1 (0.46) BRD4ALDH1A1PDPK1LRRK2HSD17B10
SCHEMBL19778900 0.74 ALDH1A1 (0.46) BRD4ALDH1A1PDPK1LRRK2HSD17B10
SCHEMBL29367441 0.74 PI4KA (0.50) BRD4ALDH1A1PDPK1LRRK2CHEK1
SCHEMBL29804946 0.74 ALDH1A1 (0.46) BRD4ALDH1A1LRRK2HSD17B10TP53
SCHEMBL7108989 0.74 PI4KA (0.50) BRD4ALDH1A1PDPK1LRRK2CHEK1
SCHEMBL323982 0.74 ALDH1A1 (0.52) BRD4ALDH1A1PDPK1LRRK2CHEK1
SCHEMBL1165562 0.74 ALDH1A1 (0.46) BRD4ALDH1A1PDPK1LRRK2HSD17B10
SCHEMBL3974202 0.74 ALDH1A1 (0.46) BRD4ALDH1A1PDPK1LRRK2HSD17B10
SCHEMBL22830483 0.74 ALDH1A1 (0.46) BRD4ALDH1A1PDPK1LRRK2HSD17B10
SCHEMBL2009562 0.74 ALDH1A1 (0.46) BRD4ALDH1A1PDPK1LRRK2CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250230157-A1 AZABENZIMIDAZOLES AND THEIR USE AS AMPA RECEPTOR MODULATORS RAPPORT THERAPEUTICS, INC. 2025-07-17 US disclosed
US-20220104496-A1 PESTICIDALLY ACTIVE BI- OR TRICYCLIC HETEROCYCLES WITH SULFUR CONTAINING SUBSTITUENTS SYNGENTA PARTICIPATIONS AG (CH) 2022-04-07 US disclosed
US-11229208-B2 Pesticidally active bi- or tricyclic heterocycles with sulfur containing substituents SYNGENTA PARTICIPATIONS AG (CH) 2022-01-25 US disclosed
US-10939682-B2 Pesticidally active bi- or tricyclic heterocycles with sulfur containing substituents SYNGENTA PARTICIPATIONS AG (CH) 2021-03-09 US disclosed
US-20210037827-A1 PESTICIDALLY ACTIVE BI- OR TRICYCLIC HETEROCYCLES WITH SULFUR CONTAINING SUBSTITUENTS SYNGENTA PARTICIPATIONS AG (CH) 2021-02-11 US disclosed
US-20170202970-A1 SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME BLINKBIO, INC. 2017-07-20 US disclosed
US-9630958-B2 Triazine compounds SPHAERA PHARMA PTE. LTD. (SG) 2017-04-25 US disclosed
US-9630958-B2 Triazine compounds SPHAERA PHARMA PTE. LTD. (SG) 2017-04-25 US disclosed
US-20160255837-A1 PESTICIDALLY ACTIVE BI- OR TRICYCLIC HETEROCYCLES WITH SULFUR CONTAINING SUBSTITUENTS SYNGENTA PARTICIPATIONS AG (CH) 2016-09-08 US disclosed
US-9346814-B2 FAP inhibitors Universiteit Antwerp (BE) 2016-05-24 US disclosed
US-20150197515-A1 NOVEL TRIAZINE COMPOUNDS SPHAERA PHARMA PTE. LTD. (SG) 2015-07-16 US disclosed
US-20150197515-A1 NOVEL TRIAZINE COMPOUNDS SPHAERA PHARMA PTE. LTD. (SG) 2015-07-16 US disclosed
WO-2015000715-A1 PESTICIDALLY ACTIVE BI- OR TRICYCLIC HETEROCYCLES WITH SULFUR CONTAINING SUBSTITUENTS SYNGENTA PARTICIPATIONS AG (CH) 2015-01-08 WO disclosed
US-20140357650-A1 NOVEL FAP INHIBITORS FOX CHASE CANCER CENTER (US) 2014-12-04 US disclosed
US-20140357650-A1 NOVEL FAP INHIBITORS FOX CHASE CANCER CENTER (US) 2014-12-04 US disclosed
WO-2014016849-A9 NOVEL TRIAZINE COMPOUNDS SPHAERA PHARMA PTE. LTD. (SG) 2014-03-13 WO disclosed
EP-1970445-B1 METHOD FOR NUCLEIC ACID REPLICATION AND NOVEL ARTIFICIAL BASE PAIRS RIKEN (JP) 2012-09-26 EP disclosed
US-8030478-B2 Method for nucleic acid replication and novel artificial base pairs RIKEN (JP) 2011-10-04 US disclosed
US-20100036111-A1 METHOD FOR REPLICATING NUCLEIC ACIDS AND NOVEL UNNATURAL BASE PAIRS RIKEN (JP) 2010-02-11 US disclosed
EP-1970445-A1 METHOD FOR NUCLEIC ACID REPLICATION AND NOVEL ARTIFICIAL BASE PAIRS Riken (JP) 2008-09-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220104496-A1 PESTICIDALLY ACTIVE BI- OR TRICYCLIC HETEROCYCLES WITH SULFUR CONTAINING SUBSTITUENTS GSTA1, CYP1B1, DDT BRD4 1618/4885ALDH1A1 149/4885PDPK1 2309/4885
US-20160255837-A1 PESTICIDALLY ACTIVE BI- OR TRICYCLIC HETEROCYCLES WITH SULFUR CONTAINING SUBSTITUENTS DDT, TST, SCLY BRD4 1327/4885ALDH1A1 2859/4885PDPK1 3878/4885
US-20170202970-A1 SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME CD44, MSN, AS3MT BRD4 3709/4885ALDH1A1 2151/4885PDPK1 2826/4885
US-20210037827-A1 PESTICIDALLY ACTIVE BI- OR TRICYCLIC HETEROCYCLES WITH SULFUR CONTAINING SUBSTITUENTS GSTA1, CYP1B1, DDT BRD4 1618/4885ALDH1A1 149/4885PDPK1 2309/4885
US-10939682-B2 Pesticidally active bi- or tricyclic heterocycles with sulfur containing substituents DDT, TST, SCLY BRD4 1327/4885ALDH1A1 2859/4885PDPK1 3878/4885
US-20100036111-A1 METHOD FOR REPLICATING NUCLEIC ACIDS AND NOVEL UNNATURAL BASE PAIRS POLM, POLL, POLRMT BRD4 1093/4885ALDH1A1 2586/4885PDPK1 3161/4885
US-11229208-B2 Pesticidally active bi- or tricyclic heterocycles with sulfur containing substituents GSTA1, CYP1B1, DDT BRD4 1618/4885ALDH1A1 149/4885PDPK1 2309/4885
US-20140357650-A1 NOVEL FAP INHIBITORS FAP, APC, FIBP BRD4 2396/4885ALDH1A1 1557/4885PDPK1 740/4885
US-20250230157-A1 AZABENZIMIDAZOLES AND THEIR USE AS AMPA RECEPTOR MODULATORS GRIN1, GRIN2B, GRIN3A BRD4 871/4885ALDH1A1 765/4885PDPK1 3052/4885
US-20150197515-A1 NOVEL TRIAZINE COMPOUNDS MTOR, PIK3R5, PIK3R2 BRD4 1220/4885ALDH1A1 3488/4885PDPK1 24/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.